RedHill Biopharma Ltd. Stock OTC Markets
Equities
REDIF
IL0011223810
Pharmaceuticals
Sales 2022 | 61.8M 84.49M | Sales 2023 | 6.53M 8.93M | Capitalization | 28.72M 39.27M |
---|---|---|---|---|---|
Net income 2022 | -71M -97.06M | Net income 2023 | 23M 31.44M | EV / Sales 2022 | 1.87 x |
Net Debt 2022 | 103M 140M | Net cash position 2023 | 4.4M 6.01M | EV / Sales 2023 | 3.73 x |
P/E ratio 2022 |
-0.12
x | P/E ratio 2023 |
0.4
x | Employees | 53 |
Yield 2022 * |
-
| Yield 2023 |
-
| Free-Float | 99% |
Managers | Title | Age | Since |
---|---|---|---|
Dror Ben-Asher
CEO | Chief Executive Officer | 59 | 09-08-02 |
Ori Shilo
FOU | Founder | 58 | 09-08-02 |
Razi Ingber
DFI | Director of Finance/CFO | - | 23-01-04 |
Members of the board | Title | Age | Since |
---|---|---|---|
Rick Scruggs
BRD | Director/Board Member | 64 | 15-12-31 |
Shmuel Cabilly
BRD | Director/Board Member | 74 | 10-08-25 |
Director/Board Member | 80 | 10-05-02 |
1st Jan change | Capi. | |
---|---|---|
+7.98% | 101B | |
+8.42% | 42.18B | |
-13.04% | 32.26B | |
+80.80% | 29.79B | |
-10.92% | 16.06B | |
+1.93% | 14.45B | |
-6.77% | 12.01B | |
+177.16% | 10.71B | |
+4.12% | 8.89B |